Search

State

Industry

Company

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement

Ampio Pharmaceuticals, Inc.

Sponsored Research Agreement Addendum No. 7 (Termination) June 30, 2017 This addendum is being entered into to modify the Sponsored Research Agreement (SRA) dated September 1, 2009 made by and between Trauma Research LLC (“TRLLC”) and Ampio Pharmaceuticals, Inc. (the “Company” or “Ampio”, formerly DMI Life Sciences, Inc.) Whereas, the SRA was entered into as of September 1, 2009; and Whereas , th

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement

Amarantus Bioscience Holdings, Inc.

ex10_5.htm Gerald Commissiong July 21, 2010 Amarantus Therapeutics, Inc. 675 Almanor Avenue Sunnyvale, CA 94085-2934 Dear Mr. Commissiong: Pursuant to our recent conversation in which we discussed a Sponsored Research Agreement ("Agreement") to more effectively pursue our mutual research interests, the following terms are set forth below and are effective July 22, 2010. SPONSORED RESEARCH AGREEME

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement dated September 1, 2009

Ampio Pharmaceuticals, Inc.

SPONSORED RESEARCH AGREEMENT DATED SEPTEMBER 1, 2009 Sponsored Research Agreement dated September 1, 2009 SPONSORED RESEARCH AGREEMENT This Sponsored Research Agreement (the “Agreement”) is made by and between Trauma Research LLC (“TRLLC”) , a Colorado limited liability company, having its address at 900 East Oxford Lane, Englewood, Colorado 80113 and DMI Life Sciences, Inc. (“Sponsor”) , a Delawa

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Sponsored Research Agreement (ver

Adynxx, Inc.

MSU SPONSORED RESEARCH AGREEMENT Sponsored Research Agreement (ver Sponsored Research Agreement (ver. 11/07/05) THIS SPONSORED RESEARCH AGREEMENT is made and effective as of the date of last signing (herein the "Effective Date") by and between Phoenix Biosystems, a subsidiary of Hepalife, Inc, (herein "Sponsor)" having its principal place of business at 216-1628 West 1st Avenue Vancouver. BC Canad

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement

Amarantus Bioscience Holdings, Inc.

ex10_5.htm Gerald Commissiong July 21, 2010 Amarantus Therapeutics, Inc. 675 Almanor Avenue Sunnyvale, CA 94085-2934 Dear Mr. Commissiong: Pursuant to our recent conversation in which we discussed a Sponsored Research Agreement ("Agreement") to more effectively pursue our mutual research interests, the following terms are set forth below and are effective July 22, 2010. SPONSORED RESEARCH AGREEME

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

[***] Certain information in this

Forestar Group Inc.

[***] Certain information in this document has been omitted from this because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SPONSORED RESEARCH AGREEMENT This Sponsored Research Agreement (“ Agreement ”) is dated as of April 23, 2018 (the “ Effective Date ”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporat

PHARMACEUTICAL PREPARATIONS

SPONSORED RESEARCH AGREEMENT

Atherogenics Inc

SPONSORED RESEARCH AGREEMENT 1 SPONSORED RESEARCH AGREEMENT This Sponsored Research Agreement (the "Agreement") is made by and between EMORY UNIVERSITY, a nonprofit Georgia corporation with offices located at 1784 North Decatur Road, Suite 510, Atlanta, Georgia 30322 ("University") and ATHEROGENICS, INC., a for profit Georgia corporation organized and existing under the laws of the State of Georgi

PHARMACEUTICAL PREPARATIONS

* Certain confidential portions

Adesto Technologies Corp

* Certain confidential portions of this were omitted by means of marking such portions with brackets (“[****]”) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed. AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENT This Amended and Restated Sponsored Research Agreement (this “ Agreement ”), effective as of the date of the

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement

Ampio Pharmaceuticals, Inc.

***Text Omitted Pursuant to a Request for Confidential Treatment and Filed Separately with the Securities and Exchange Commission Sponsored Research Agreement Addendum No. 4 March 17, 2014 As a result of the need to accelerate the accumulation of (1) more clinical and laboratory data in support of additional indications for the Company’s drugs currently in clinical studies and (2) to move other d

PHARMACEUTICAL PREPARATIONS

Sponsored Research Agreement

Aeolus Pharmaceuticals, Inc.

*** Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240.24b-2 SPONSORED RESEARCH AGREEMENT (NON-CLINICAL) This agreement (“AGREEMENT”) is between DUKE UNIVERSITY (“DUKE”), a North Carolina non-profit corporation, located in Durham, North Carolina, and AEOLUS PHARMACEUTICALS, INC. (“AEOLUS”), a Delaware Corporation having offices at 26361 Crow